6-31112207-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000259870.4(C6orf15):c.152C>T(p.Ser51Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,614,144 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000259870.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C6orf15 | NM_014070.3 | c.152C>T | p.Ser51Phe | missense_variant | 2/2 | ENST00000259870.4 | NP_054789.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C6orf15 | ENST00000259870.4 | c.152C>T | p.Ser51Phe | missense_variant | 2/2 | 1 | NM_014070.3 | ENSP00000259870 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000641 AC: 16AN: 249468Hom.: 0 AF XY: 0.0000887 AC XY: 12AN XY: 135326
GnomAD4 exome AF: 0.0000650 AC: 95AN: 1461848Hom.: 1 Cov.: 41 AF XY: 0.0000605 AC XY: 44AN XY: 727234
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152296Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | The c.152C>T (p.S51F) alteration is located in exon 2 (coding exon 2) of the C6orf15 gene. This alteration results from a C to T substitution at nucleotide position 152, causing the serine (S) at amino acid position 51 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at